TuHURA Biosciences (HURA) Debt Ratio (2011 - 2025)

TuHURA Biosciences (HURA) posted quarterly Debt Ratio of 0.02 for Q4 2025, down 6.05% quarter-over-quarter from 0.02 in Q3 2025.

TuHURA Biosciences (HURA) Debt Ratio (2011 - 2025) Analysis & Trends

TuHURA Biosciences' Debt Ratio history runs 14 years deep, the most recent figure standing at 0.02 for Q4 2025.

In Q4 2025, Debt Ratio changed N/A year-over-year to 0.02; the TTM figure through Dec 2025 stood at 0.02 (changed N/A YoY), while the FY2025 annual figure was 0.02, changed N/A from the prior year.
Debt Ratio for Q4 2025 stood at 0.02, down from 0.02 in the prior quarter.
The five-year high for Debt Ratio was 0.07 in Q2 2023, with the low at 0.02 in Q4 2025.
The 4-year median for Debt Ratio is 0.04 (2021), against an average of 0.04.
The sharpest annual moves came in 2021 and 2022: Debt Ratio tumbled 81.67% in 2021, then soared 97.38% in 2022.
TuHURA Biosciences' Debt Ratio stood at 0.03 in 2021, then soared by 80.31% to 0.06 in 2022, then surged by 35.53% to 0.07 in 2023, then tumbled by 71.1% to 0.02 in 2025.
Business Quant data shows HURA's Debt Ratio at 0.02 in Q4 2025, 0.02 in Q3 2025, and 0.07 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.05
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.03
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.47
10	TuHURA Biosciences	37.61 Mn	37.61 Mn	-	-

Download Data